These findings suggest that Nosustrophine is an epinutraceutical bioproduct that functions by downregulating HDAC3 mRNA levels in vivo, which may help to ameliorate AD-related neurodegeneration. This evidence concerns the gene HDAC3 and Alzheimer disease.